Crossmark

Effects of food and ethnicity on the pharmacokinetics of venadaparib, a next-generation PARP inhibitor, in healthy Korean, Caucasian, and Chinese male subjects

Crossref DOI link: https://doi.org/10.1007/s10637-023-01405-z

Published Online: 2023-12-15

Published Print: 2024-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Kim, Hyun Chul https://orcid.org/0000-0002-8819-4780
Yang, Eunsol https://orcid.org/0000-0003-2581-349X
Lee, Soyoung https://orcid.org/0000-0001-5799-4489
Oh, Jaeseong https://orcid.org/0000-0001-6275-8587
Lee, Myongjae https://orcid.org/0000-0002-0306-6908
Lee, ChaeEun https://orcid.org/0009-0005-4285-4439
Ha, Kyoung Soo https://orcid.org/0000-0002-1216-7516
Lee, Won Sik https://orcid.org/0000-0001-9502-2429
Jang, In-Jin https://orcid.org/0000-0002-8384-3139
Yu, Kyung-Sang https://orcid.org/0000-0003-0921-7225
Funding

Funding for this research was provided by:

Idience Co., Ltd.
License Information

Text and Data Mining valid from 2023-12-15

Version of Record valid from 2023-12-15
More Information

Article History

Received: 20 September 2023

Accepted: 26 October 2023

First Online: 15 December 2023

Declarations

:

: Myongjae Lee and ChaeEun Lee are employees of Idience Co., Ltd., and Kyoung Soo Ha is an employee of Idience Inc. Won Sik Lee is the CEO of Idience Co., Ltd. The other authors declare no conflicts of interest.

Document is current

Any future updates will be listed below